{
    "2018-04-25": [
        [
            {
                "time": "2018-04-24",
                "original_text": "Biotech Stock Roundup: PRTA Down, AMGN Revises View, BIIB Misses on Sales",
                "features": {
                    "keywords": [
                        "PRTA",
                        "AMGN",
                        "BIIB",
                        "Revises View",
                        "Misses on Sales"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Edited Transcript of LLY earnings conference call or presentation 24-Apr-18 1:00pm GMT",
                "features": {
                    "keywords": [
                        "LLY",
                        "earnings",
                        "conference call"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "HDV, UPS, LLY, D: Large Outflows Detected at ETF",
                "features": {
                    "keywords": [
                        "HDV",
                        "UPS",
                        "LLY",
                        "Large Outflows",
                        "ETF"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "ETFs"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Sanofi’s 1Q18: Revenue Expected to Fall",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Revenue",
                        "Expected to Fall"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "GlaxoSmithKline: Operating Revenues Up in 1Q18 Earnings",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "Operating Revenues",
                        "Up",
                        "1Q18 Earnings"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Amgen’s Earnings Grow 12% Year-Over-Year in 1Q18",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Earnings",
                        "Grow",
                        "12%",
                        "Year-Over-Year",
                        "1Q18"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Analysts Expect Bristol-Myers Squibb to Post Revenue Growth in 1Q18",
                "features": {
                    "keywords": [
                        "Bristol-Myers Squibb",
                        "Revenue Growth",
                        "1Q18"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Novo Nordisk’s New-Generation Insulins: Growth Driver for 2018?",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "New-Generation Insulins",
                        "Growth Driver",
                        "2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Why Incyte Stock Fell ~9% on April 24",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Stock Fell",
                        "~9%",
                        "April 24"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Novo Nordisk’s Xultophy Expected to See High Growth in 2018",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Xultophy",
                        "High Growth",
                        "2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "How Johnson & Johnson’s Medical Devices Segment Performed in 1Q18",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Medical Devices",
                        "Segment Performed",
                        "1Q18"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Is Eli Lilly and Company a Buy?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Buy"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Lilly and China's NCCD announce collaboration to advance scientific understanding and care for people living with diabetes and cardiovascular disease",
                "features": {
                    "keywords": [
                        "Lilly",
                        "China's NCCD",
                        "collaboration",
                        "diabetes",
                        "cardiovascular disease"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}